ArticleFrontiers in pharmacology2024

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database.

Dan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.